New technique generates rod photoreceptors that integrate into the retina and brain.
Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors. The findings advance efforts toward regenerative therapies for blinding diseases such as age-related macular degeneration and retinitis pigmentosa. A report of the findings appears online today in Nature. NEI is part of the National Institutes of Health.
“This is the first report of scientists reprogramming Müller glia to become functional rod photoreceptors in the mammalian retina,” said Thomas N. Greenwell, Ph.D., NEI program director for retinal neuroscience. “Rods allow us to see in low light, but they may also help preserve cone photoreceptors, which are important for color vision and high visual acuity. Cones tend to die in later-stage eye diseases. If rods can be regenerated from inside the eye, this might be a strategy for treating diseases of the eye that affect photoreceptors.”
Photoreceptors are light-sensitive cells in the retina in the back of the eye that signal the brain when activated. In mammals, including mice and humans, photoreceptors fail to regenerate on their own. Like most neurons, once mature they don’t divide.
Scientists have long studied the regenerative potential of Müller glia because in other species, such as zebrafish, they divide in response to injury and can turn into photoreceptors and other retinal neurons. The zebrafish can thus regain vision after severe retinal injury. In the lab, however, scientists can coax mammalian Müller glia to behave more like they do in the fish. But it requires injuring the tissue.
“From a practical standpoint, if you’re trying to regenerate the retina to restore a person’s vision, it is counterproductive to injure it first to activate the Müller glia,” said Bo Chen, Ph.D., associate professor of ophthalmology and director of the Ocular Stem Cell Program at the Icahn School of Medicine at Mount Sinai, New York.
“We wanted to see if we could program Müller glia to become rod photoreceptors in a living mouse without having to injure its retina,” said Chen, the study’s lead investigator.
In the first phase of a two-stage reprogramming process Chen’s team spurred Müller glia in normal mice to divide by injecting their eyes with a gene to turn on a protein called beta-catenin. Weeks later, they injected the mice’s eyes with factors that encouraged the newly divided cells to develop into rod photoreceptors.
The researchers used microscopy to visually track the newly formed cells. They found that the newly formed rod photoreceptors looked structurally no different from real photoreceptors. In addition, synaptic structures that allow the rods to communicate with other types of neurons within the retina had also formed. To determine whether the Müller glia-derived rod photoreceptors were functional, they tested the treatment in mice with congenital blindness, which meant that they were born without functional rod photoreceptors.
In the treated mice that were born blind, Müller glia-derived rods developed just as effectively as they had in normal mice. Functionally, they confirmed that the newly formed rods were communicating with other types of retinal neurons across synapses. Furthermore, light responses recorded from retinal ganglion cells — neurons that carry signals from photoreceptors to the brain — and measurements of brain activity confirmed that the newly-formed rods were in fact integrating in the visual pathway circuitry, from the retina to the primary visual cortex in the brain.
Chen’s lab is conducting behavioral studies to determine whether the mice have regained the ability to perform visual tasks such as a water maze task. Chen also plans to see if the technique works on cultured human retinal tissue.
Receive an email update when we add a new CONGENITAL BLINDNESS article.
The Latest on: Congenital blindness
via Google News
The Latest on: Congenital blindness
- Scientists Reverse Congenital Blindness in Mice on August 20, 2018 at 6:29 am
A team of scientists led by the Icahn School of Medicine at Mount Sinai has successfully reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod ph... […]
- Scientists reverse congenital blindness in mice on August 16, 2018 at 1:38 am
Washington, Aug 16 (IANS) In a breakthrough, US researchers have reversed congenital blindness in mice by activating cells in the retina, advancing treatment for retinal degenerative diseases which cu... […]
- Reprogramming retina cells found to reverse blindness in mice on August 15, 2018 at 7:56 pm
In the study, scientists managed to restore vision in mice born with congenital blindness, using gene therapy to reprogram base retinal cells into functioning rod photoreceptors. We owe our vision to ... […]
- Researchers restore mice vision using retinal stem cells on August 15, 2018 at 10:22 am
Researchers reported in a study published on Wednesday in the journal Nature that they reversed congenital blindness in mice by changing supportive cells in the retina called Muller glia into rod phot... […]
- Researchers reverse congenital blindness in mice on August 15, 2018 at 10:00 am
An artist's rendering incorporates the images of the Müller glia-derived rod photoreceptors. These photoreceptors were structurally no different from real photoreceptors and they became integrated wit... […]
- AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness on February 3, 2018 at 4:00 pm
1 F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, 309 Stellar-Chance Labs, 422 Curie Boulevard, Philadelphia, PA 19104, USA. 2 Center for Cellular and ... […]
- “More on the enigma of blindness and psychosis” on November 6, 2017 at 6:41 am
Based on the rates of occurrence for each condition, the combination should be fairly common. This suggests that hypothesis of protective effects of congenital blindness needs to taken seriously.&rdquo […]
- New Drug Treats Congenital Blindness on January 22, 2015 at 4:13 pm
A new oral drug can improve vision in people with a specific form of blindness, researchers announced in July. A team led by pediatric ophthalmologist Robert Koenekoop at McGill University gave the me... […]
- New study sheds light on the complexity of gene therapy for congenital blindness on January 22, 2013 at 8:35 am
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenita... […]
via Bing News